GKHT Medical Technology Completed More Than 1.1 Billion C Round of Financing, To Improve Digital Services of Medical Devices’ s Supply Chain

According to VCbeat, Guoke Hengtai (Beijing) Medical Technology co., LTD.  (GKHT Medical Technology) held its successful C round financing conference. Hengtai group officially announced that the company had completed the C round of financing, which is a project with the largest financing scale exceeding 1.1 billion in the Chinese medical device circulation field since 2019.

The financing was led by Taikang Life Insurance, and jointly invested by 6 Dimensions Capital, China Merchants Capital, Yongliu Capital, Legend Capital, Sherpa Capital, CASH Capital, Longwin Capital and so on. 

 This round of financing would be used for the construction of the "digital supply chain services platform" project and "digital ecological platform for medical devices industry "in Tianjin, in order to further improve supply ability and information system.

GKHT Medical Technology was established in February 2013 and is affiliated to Oriental Science and Technology Holding Group Co., Ltd. (Oriental Instrument), a subsidiary of the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. It is headquartered in Yizhuang Economic and Technological Development Zone, Beijing. Up to now, GKHT Medical Technology has got two rounds of investment in A and B, and its performance has continued to grow at a high speed, with a compound annual growth rate of over 80%.

As an industry leader and the innovation leader, GKHT Medical Technology has created an innovative business pattern about "one-stop supply chain management with service platforms” and constructed an information system from the original factory to departments in the hospital, which can help to track the whole supply process.

6 Dimensions Capital was established in May 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures. The two prominent and experienced teams formed a healthcare-focused investment firm with an in-depth focus and extensive coverage both in China and the global market.

Headquatered in both Shenzhen and Hong Kong, China Merchants Capital Management Co., Ltd was founded in 2012 with a registered capital of $160 Million (USD, hereinafter). As the subsidiary of China Merchants Group ("CM Group"), CMC is the investment management platform of it, specializing in alternative investments and management.

CMC seeks cooperation opportunities in the following sectors: infrastructure, medical & pharmaceutical, financial services, real estate, high-tech, agriculture & foods, media, equipment machinery, mining, energy, etc.

Longwin Capital is a member of the Asset Management Association of China, founded by veteran investment professionals in April 2015. Currently, it has 10 RMB private equity funds under management, which are mainly invested in industries of healthcare, TMT, new energy and blockchain technology. 

The company also keeps track of companies that would benefit from domestic consumption upgrade and actively explore the opportunities emerging from M&A activities in those industries.